Jump to content
ACN Latitudes Forums

3/09 Article to certify education units for Doctors....rx sore throat


Recommended Posts

Management of Streptococcal Pharyngitis Reviewed CME/CE

News Author: Laurie Barclay, MD

CME Author: Désirée Lie, MD, MSEd

Disclosures

 

Release Date: March 10, 2009; Valid for credit through March 10, 2010 Credits Available

 

Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s)™ for physicians;

Family Physicians - up to 0.25 AAFP Prescribed credit(s) for physicians;

Nurses - 0.25 ANCC contact hours (0.25 contact hours are in the area of pharmacology)

 

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

 

 

 

Learning Objectives

Upon completion of this activity, participants will be able to:

 

Describe the prevalence, presentation, and diagnosis of group A beta-hemolytic streptococcus pharyngitis.

Describe treatment and follow up guidelines for acute, chronic, and recurrent group A beta-hemolytic streptococcus pharyngitis

Authors and Disclosures

Laurie Barclay, MD

Disclosure: Laurie Barclay, MD, has disclosed no relevant financial relationships.

 

 

 

Désirée Lie, MD, MSEd

Disclosure: Désirée Lie, MD, MSEd, has disclosed no relevant financial relationships.

 

 

 

Laurie Scudder, MS, NP

Disclosure: Laurie Scudder, MS, NP, has disclosed no relevant financial information.

 

 

 

Brande Nicole Martin

Disclosure: Brande Nicole Martin has disclosed no relevant financial information.

 

 

March 10, 2009 — Best practices to diagnose and treat streptococcal pharyngitis in the primary care setting are reviewed in an article published in the March 1 issue of American Family Physician.

 

"Pharyngitis is diagnosed in 11 million patients in U.S. emergency departments and ambulatory settings annually," writes Beth A. Choby, MD, from University of Tennessee College of Medicine in Chattanooga. "Group A beta-hemolytic streptococcus (GABHS), the most common bacterial etiology, accounts for 15 to 30 percent of cases of acute pharyngitis in children and 5 to 20 percent in adults....The infection is transmitted via respiratory secretions, and the incubation period is 24 to 72 hours."

 

In addition to sore throat, signs and symptoms frequently associated with streptococcal pharyngitis include fever with temperature greater than 100.4°F (38°C), tonsillar exudates, and cervical adenopathy. Viral pharyngitis is more likely than streptococcal pharyngitis to be associated with cough, coryza, and diarrhea.

 

The gold standard for streptococcal pharyngitis is throat culture. However, there have been significant improvements in sensitivity and specificity of rapid antigen detection testing (RADT). To facilitate management, the modified Centor score can help clinicians determine which patients should need no testing, throat culture/RADT, or empiric treatment with antibiotics.

 

The Centor clinical decision rule allowing clinicians to determine appropriate management of patients with sore throat assigns 1 point for each of the following: absence of cough, swollen and tender anterior cervical nodes, elevated temperature of more than 100.4°F (38°C), tonsillar exudates or swelling, and ages 3 to 14 years. One point is subtracted for age 45 years and older.

 

For a score of 0 to 1, the risk for GABHS pharyngitis is 1% to 2.5% (score ≤ 0) or 5% to 10% (score 1), and no further testing or antibiotics are indicated, although throat culture or RADT may be performed for a score of 1. Other factors should be considered, such as recent family contact with documented streptococcal infection, which would lower the threshold for testing and/or treatment.

 

For a score of 2 or 3, the risk for GABHS pharyngitis is 11% to 18% (score 2) up to 28% to 35% (score 3), and throat culture or RADT should be performed and antibiotics given if culture results are positive.

 

For a score of 4 or more, the risk for GABHS pharyngitis is 51% to 53%, and empiric treatment with antibiotics should be considered.

 

"Although GABHS pharyngitis is common, the ideal approach to management remains a matter of debate," the review authors write. "U.S. guidelines differ in whether they recommend using clinical prediction models versus diagnostic testing. Several international guidelines recommend not testing for or treating GABHS pharyngitis at all."

 

Complications of GABHS pharyngitis may be either suppurative or nonsuppurative. The suppurative complications may include bacteremia, cervical lymphadenitis, endocarditis, mastoiditis, meningitis, otitis media, peritonsillar or retropharyngeal abscess, and/or pneumonia. Nonsuppurative complications may include poststreptococcal glomerulonephritis or rheumatic fever.

 

The treatment of choice for streptococcal pharyngitis is penicillin (10 days of oral treatment or 1 injection of intramuscular benzathine penicillin) because of cost, narrow spectrum of activity, and efficacy. However, amoxicillin tastes better and is equally effective. In patients with penicillin allergy, reasonable options are erythromycin and first-generation cephalosporins.

 

There have been reports of increased GABHS treatment failure with penicillin. Therefore, some guidelines recommend use of cephalosporins in all nonallergic patients, and not just in persons with penicillin allergy, because of improved eradication of GABHS and greater efficacy against chronic carriage of GABHS.

 

Despite appropriate antibiotic treatment, chronic GABHS colonization is common. There is generally no need to treat chronic carriers because they are thought to be at low risk of transmitting disease or developing invasive GABHS infections.

 

Persons or situations in which antibiotic treatment of chronic GABHS colonization may be appropriate include recurrent GABHS infection within a family; personal history of or close contact with a person with acute rheumatic fever or acute poststreptococcal glomerulonephritis; close contact with a person with group A streptococcal infection; community outbreak of acute rheumatic fever, poststreptococcal glomerulonephritis, or invasive group A streptococcal infection; healthcare workers or patients in hospitals, chronic care facilities, or nursing homes; families who cannot be reassured without antibiotic treatment; and children who are at risk for tonsillectomy for repeated GABHS pharyngitis.

 

It is still unclear whether tonsillectomy or adenoidectomy reduces the incidence of GABHS pharyngitis, but the potential benefits are thought to be too small to outweigh the associated costs and surgical risks.

 

Specific clinical recommendations for practice, and their accompanying level of evidence rating, are as follows:

 

Use of clinical decision rules to diagnose GABHS pharyngitis is associated with better quality of care, less unnecessary treatment, and lower overall cost (level of evidence, A).

In persons who are not penicillin-allergic, penicillin is the treatment of choice for GABHS pharyngitis (level of evidence, A).

Chronic carriers of pharyngeal GABHS typically do not require treatment (level of evidence, C).

"Differences in guidelines are best explained by whether emphasis is placed on avoiding inappropriate antibiotic use or on relieving acute GABHS pharyngitis symptoms," the review authors conclude. "Several U.S. guidelines recommend confirmatory throat culture for negative RADT in children and adolescents."

 

Dr. Choby is an assistant editor of The Core Content Review of Family Medicine.

 

Am Fam Physician. 2009;79:383-390.

 

Clinical Context

Streptococcal pharyngitis is diagnosed in 11 million patients in US emergency and ambulatory settings annually, and GABHS infection accounts for 15% to 30% of acute pharyngitis in children and 5% to 20% in adults. Late winter and early spring are peak GABHS seasons, and the incubation period is 24 to 72 hours. One in 4 children with acute sore throat has serologically confirmed GABHS pharyngitis, and 43% of families with an index case have a secondary case. The incidence of rheumatic fever has decreased dramatically in developed countries, but it remains a problem in low-income and middle-income countries, with an annual incidence of 5 per 1000 persons.

 

This is a review of current guidelines for the diagnosis and management of acute recurrent and chronic GABHS pharyngitis.

 

Study Highlights

No single history or physical examination finding reliably confirms or excludes GABHS pharyngitis.

Sore throat, sudden-onset fever with an elevated temperature greater than 100.4°F (38°C), and exposure to streptococcus within 2 weeks suggest infection.

Common physical signs include cervical adenopathy and pharyngeal or tonsillar inflammation or exudates; palatal petechiae or scarlatiniform rash are specific but uncommon.

Cough, coryza, conjunctivitis, and diarrhea are more common with virus infection.

The Centor score uses 4 signs and symptoms and a scale of 0 to 4 for diagnosis.

A score of 0 to 1 indicates low risk.

A score of 2 to 3 indicates a need for testing with RADT or throat culture and treatment for positive test results.

A score of 4 indicates that empiric treatment is indicated, even without positive results on cultures.

A single throat culture is 90% to 95% sensitive.

RADT allows for earlier treatment vs culture, with specificity and sensitivity ranging from 90% to 99% in the newer enzyme-linked immunosorbent assays and a sensitivity of approximately 70% with the older latex agglutination assays.

Whether a negative RADT result requires confirmatory culture is controversial.

The American Academy of Pediatrics recommends confirmation in children unless RADT sensitivity is similar to throat culture.

Back-up cultures are sometimes not performed because of concerns about false-positive results and unnecessary antibiotic use.

Several US practice guidelines recommend confirmatory throat culture for negative RADT result in children and adolescents because this method is 100% sensitive and 99% to 100% specific in children.

GABHS is self-limiting and resolves within a few days.

The rationale for antibiotic treatment is prevention of suppurative infection, prevention of rheumatic fever, and reduction of communicability.

Antibiotics shorten symptoms by 16 hours, with a number needed to treat of 4 in those with a positive result on throat culture.

Children with GABHS may return to school after 24 hours of antibiotic treatment.

The antibiotic of choice is penicillin because no increase in resistance has been seen for the past 50 years.

Oral penicillin, a single dose of intramuscular penicillin G, penicillin congeners (ampicillin or amoxicillin), clindamycin, and some cephalosporins and macrolides are effective against GABHS.

Oral amoxicillin is well tolerated and has an 85% eradication rate.

Once-daily dosing of amoxicillin in children aged 3 to 18 years is not inferior to twice-daily dosing but is not approved by the US Food and Drug Administration.

Erythromycin is recommended for patients with penicillin allergy, but resistance rates to erythromycin in the United States and Canada can approach 8% to 9%

First-generation cephalosporins may be used for patients with penicillin allergy who do not have immediate-type hypersensitivity to beta-lactam antibiotics.

Recurrence of GABHS within 1 month may be treated with antibiotics or intramuscular penicillin.

Chronic carriage of GABHS can occur up to 1 year after infection, but the risk for transmission is low.

Antibiotic treatment may be appropriate in the following persons or situations: recurrent GABHS in the family, history or contact with someone who has rheumatic fever or acute poststreptococcal glomerulonephritis, close contact with someone who has invasive group A streptococcal infection, or healthcare workers.

Although children with tonsils are 3 times more likely to have GABHS pharyngitis, the effect of tonsillectomy on decreasing the risk for chronic or recurrent tonsillitis is poorly understood.

Pearls for Practice

The diagnosis of GABHS pharyngitis is made by a combination of clinical symptoms and signs, RADT, and throat culture.

Antibiotic treatment is indicated to reduce communicability, prevent suppurative infection, and prevent rheumatic fever. Penicillin is the preferred initial treatment of GABHS.

CME/CE Test

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
×
×
  • Create New...